Xenon Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.About XENE
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
XENE Key Statistics
Stock Snapshot
Xenon Pharmaceuticals(XENE) stock is priced at $55.20, giving the company a market capitalization of 4.6B. It carries a P/E multiple of -12.66.
On 2026-03-18, Xenon Pharmaceuticals(XENE) stock moved within a range of $54.19 to $56.19. With shares now at $55.20, the stock is trading +1.9% above its intraday low and -1.8% below the session's peak.
Trading volume for Xenon Pharmaceuticals(XENE) stock has reached 993.56K, versus its average volume of 3.33M.
Over the past 52 weeks, Xenon Pharmaceuticals(XENE) stock has traded between a high of $63.95 and a low of $26.74.
Over the past 52 weeks, Xenon Pharmaceuticals(XENE) stock has traded between a high of $63.95 and a low of $26.74.
XENE News
Xenon Pharmaceuticals (XENE) has drawn fresh attention after reporting positive Phase 3 X TOLE2 results for azetukalner in focal onset seizures, followed closel...
Xenon ( (XENE) ) has shared an update. Xenon Pharmaceuticals Inc. advised Canadian securities regulators on March 13, 2026 that it has set June 2, 2026 as the...
Xenon Pharmaceuticals (XENE) announced an update on their ongoing clinical study. Xenon Pharmaceuticals Inc. (XENE) has completed its Phase 3 X-TOLE2 trial, of...
Analyst ratings
100%
of 20 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.